Related Experiment Video

Updated: Jun 14, 2025

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.6K

Management of fulminant botulism after allogeneic hematopoietic cell transplantation

Nao Takasugi1, Kaname Uchida1, Konomi Shimoda1

  • 1Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Pediatric Blood & Cancer
|September 4, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
10:49

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Published on: September 18, 2011

20.6K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.2K

Related Experiment Videos

Last Updated: Jun 14, 2025

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.6K
Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
10:49

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Published on: September 18, 2011

20.6K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.2K

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

316
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
316
Tissue Transplantation01:24

Tissue Transplantation

346
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
346

Articles linked to this work by shared authors, journal, and citation graph.

Efficacy and safety of risk-stratified chemotherapy with azacitidine for children with myeloid leukaemia with Down syndrome: protocol for a multicentre phase II trial (JCCG AML-D24).

BMJ open·2026

Personalized reference genome-based pipeline reveals comprehensive haplotype-resolved views of cancer genomes.

bioRxiv : the preprint server for biology·2026

Multifocal Neuroblastoma in Rubinstein-Taybi Syndrome Harboring a Novel CREBBP Variant Identified by Paired Whole Genome Sequencing.

Congenital anomalies·2026

Decreased renal function predicts severe cytokine release syndrome after CAR-T-cell therapy for large B-cell lymphoma.

British journal of haematology·2026

Phenotypic Expansion and Molecular Implications in Recessive FUZ -Related Ciliopathy.

Clinical genetics·2026

Trends in procedural closure of patent ductus arteriosus among children from 2011 to 2022 in Japan.

Pediatrics international : official journal of the Japan Pediatric Society·2026

Maternal Parenting Behaviors, Coping Styles, and Children's Coping With Cancer: A Cross-Sectional Study.

Pediatric blood & cancer·2026

Single Autologous Stem Cell Rescue After Single or Tandem 131I-Metaiodobenzylguanidine Therapy, With or Without Subsequent Chemotherapy, for Resistant Neuroblastoma: Feasibility, Toxicity, and Response.

Pediatric blood & cancer·2026

Venetoclax-Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia.

Pediatric blood & cancer·2026

Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital-Based Study in Indonesia.

Pediatric blood & cancer·2026

Home-Based, Connected Care: Dinutuximab Beta Immunotherapy in Neuroblastoma Beyond Feasibility. Improving Quality of Life and Family Satisfaction.

Pediatric blood & cancer·2026

Augmented Reality-Supported Cognitive Behavioral Therapy for Children With Cancer: A Multicenter, Three-Arm Randomized Controlled Trial.

Pediatric blood & cancer·2026

Targeted Intracranial Delivery of Secreted Immune Molecules to Investigate Neuroimmune Interactions.

Journal of visualized experiments : JoVE·2026

Pilot study of Wilms tumor 1-targeted human platelet lysate-induced antigen-presenting cells in advanced solid cancer patients.

Regenerative therapy·2026

Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications.

Regenerative therapy·2026

Beyond immune suppression: regenerative programs in regulatory T cells.

Cell insight·2026

Chimeric antigen receptor T cell therapy in autoimmune neurological disease: current status of efficacy and safety.

BMJ neurology open·2026

DOTAM-TCB: Universal Small Molecule-guided Hapten- and T Cell-bispecific Antibodies for Cancer Immunotherapy.

Antibody therapeutics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us